HK48094A - Purification of recombinant hepatitis B surface antigen - Google Patents

Purification of recombinant hepatitis B surface antigen

Info

Publication number
HK48094A
HK48094A HK48094A HK48094A HK48094A HK 48094 A HK48094 A HK 48094A HK 48094 A HK48094 A HK 48094A HK 48094 A HK48094 A HK 48094A HK 48094 A HK48094 A HK 48094A
Authority
HK
Hong Kong
Prior art keywords
antigen
purification
surface antigen
yeast
daltons
Prior art date
Application number
HK48094A
Other languages
English (en)
Inventor
William M Hurni
Dennis J Kubek
William J Miller
Mark S Rienstra
Edward M Scolnick
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK48094A publication Critical patent/HK48094A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
HK48094A 1987-03-09 1994-05-12 Purification of recombinant hepatitis B surface antigen HK48094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2334787A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
HK48094A true HK48094A (en) 1994-05-20

Family

ID=21814559

Family Applications (1)

Application Number Title Priority Date Filing Date
HK48094A HK48094A (en) 1987-03-09 1994-05-12 Purification of recombinant hepatitis B surface antigen

Country Status (10)

Country Link
EP (1) EP0291146B1 (xx)
JP (1) JPS63270629A (xx)
AT (1) ATE93891T1 (xx)
AU (1) AU608813B2 (xx)
CA (1) CA1304887C (xx)
CY (1) CY1790A (xx)
DE (1) DE3883596T2 (xx)
DK (1) DK123288A (xx)
ES (1) ES2043808T3 (xx)
HK (1) HK48094A (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960023066A (ko) * 1994-12-10 1996-07-18 성재갑 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
JPS62298536A (ja) * 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
ATE91304T1 (de) * 1987-02-27 1993-07-15 Merck & Co Inc Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Also Published As

Publication number Publication date
ATE93891T1 (de) 1993-09-15
EP0291146B1 (en) 1993-09-01
DE3883596D1 (de) 1993-10-07
CY1790A (en) 1995-10-20
CA1304887C (en) 1992-07-07
AU608813B2 (en) 1991-04-18
DE3883596T2 (de) 1994-02-17
DK123288D0 (da) 1988-03-08
DK123288A (da) 1988-09-10
JPS63270629A (ja) 1988-11-08
EP0291146A2 (en) 1988-11-17
AU1277888A (en) 1988-09-08
ES2043808T3 (es) 1994-01-01
EP0291146A3 (en) 1989-12-06

Similar Documents

Publication Publication Date Title
ATE224956T1 (de) Verfahren zur verstärkten expression von virusproteinen
CA2020668A1 (en) Fused or hybrid protein comprising viral antigen and lymphokine
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
EP0401941A3 (en) Hepatitis b virus surface antigen and production thereof
FI19992546A (fi) Hepatiitti B:n S- ja PreS2-proteiinien ilmentäminen metylotrofisissa hiivoissa
EP0423224A4 (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ATE243755T1 (de) Rekombinente adenoviren-impfstoffe
GR3007031T3 (xx)
EP0291146A3 (en) Purification of recombinant hepatitis b surface antigen
IL88377A0 (en) Molecular cloning of the human interferon type 1 receptor
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
EP0433378A4 (en) Allelic variants of -i(plasmodium falciparum) merozoite surface antigen
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
EP0293201A3 (en) Method of vaccination for hepatitis b virus
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.